Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Open-market buy 10% owner bought 72,500 shares at an average $8.62 ($624,697)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy 10% owner bought 20,000 shares at an average $7.31 ($146,290)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy 10% owner bought 74,584 shares at an average $8.34 ($622,389)
  11. 4 Open-market sale Director sold 10,000 shares at $10.75 ($107,500)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 49,832 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 334,129 shares (to pay taxes)
  14. 4 Open-market sale 10% owner sold 1,518,000 shares at $7.00 ($10,626,000)
  15. 4 Exercise or conversion Chief Executive Officer acquired 200,000 shares (option exercise)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 7,500 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy 10% owner bought 106,416 shares at an average $5.26 ($559,482)

Page 6 of 15 · 296 filings